C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2011
08/31/2011	CN102171194A Pyrimidine compounds, compositions and methods of use
08/31/2011	CN102171190A Insecticidal benzenedicarboxamide derivative
08/31/2011	CN102167664A Fluorine-containing rare earth salt and applications thereof
08/31/2011	CN101638352B Aryl-replaced nitrogen heterocyclic compound preparation method
08/31/2011	CN101591302B Preparation technique of heptenoic acid ester derivative
08/31/2011	CN101121698B Diarylmiazines derivatives, preparation method and use thereof
08/30/2011	US8008488 Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands
08/30/2011	US8008484 Use of sulfonanilides as agricultural and horticultural fungicide
08/30/2011	US8008312 CXCR4 antagonists for the treatment of HIV infection
08/30/2011	US8008311 Methods and compostions utilizing quinazolinones
08/30/2011	US8008307 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
08/30/2011	CA2472293C Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/25/2011	WO2011103536A1 Multifunctional radical quenchers and their use
08/25/2011	WO2011103457A1 Pyrimidine derivatives
08/25/2011	WO2011103196A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	WO2011103055A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
08/25/2011	WO2011101740A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
08/25/2011	WO2011100840A1 Substituted 2-imidazolidones and analogs
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	WO2011003528A3 Substituted phenyl(oxy/thio)alkanol derivatives
08/25/2011	US20110207932 Process for preparing aminocrotonylamino-substituted quinazoline derivatives
08/25/2011	US20110207757 Tricyclic Compounds Having Cytostatic and/or Cytoxic Activity and Methods of Use Thereof
08/25/2011	US20110207749 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207748 Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof
08/25/2011	US20110207735 Cyanopyrimidinones
08/25/2011	US20110207157 Labelling of Fusion Proteins With Synthetic Probes
08/25/2011	US20110204354 Indenopyrene compound and organic light-emitting device using the compound
08/25/2011	CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	CA2788072A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
08/25/2011	CA2787860A1 Substituted 2-imidazolidones and analogs
08/24/2011	EP2360156A1 Method for manufacturing neuraminic acid derivatives
08/24/2011	EP2358686A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
08/24/2011	EP2358685A1 Process for the preparation of substituted phenylalanines
08/24/2011	EP2358684A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
08/24/2011	EP2358677A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
08/24/2011	EP2358666A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
08/24/2011	EP1809610B1 Production method of pyrimidine compounds
08/24/2011	EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
08/24/2011	CN102164898A Process for the synthesis of halogenated cyclic compounds
08/24/2011	CN102164896A Phenethylamide derivatives and their heterocyclic analogues
08/24/2011	CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof
08/24/2011	CN102161607A Method for preparing fluorine-containing aromatic compound
08/24/2011	CN101528715B 2-phenyl-6-aminocarbonyl-pyrimidine derivatives
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/23/2011	US8003789 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
08/23/2011	US8003788 To a cooled solution of ammonia was added the cooled sulfolane solution of 5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonyl chloride to form -(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide sulfolane solvate
08/23/2011	US8003787 Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
08/23/2011	US8003673 Daptomycin for the treatment of biofilm and catheter salvage
08/23/2011	US8003658 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
08/23/2011	US8003655 Dysregulated vascular growth diseases; tyrosine kinase with immunoglobulin and epidermal growth factor homology domain inhibitors
08/23/2011	US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
08/23/2011	US8003645 type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives
08/23/2011	US8003643 Inhibitors of Akt activity
08/23/2011	US8003227 Organic electroluminescent element
08/23/2011	CA2486078C Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
08/18/2011	WO2011098607A1 Salts and hydrates of 4-[(3-chlor-4-fluoro-phenyl)amino]-6-(cis-4-{n-[(morph-1-olino-4-yl)carbonyl]-n-methyl-amino}-cyclohexane-1-yloxy)-7-methoxy-quinazoline, their use as drugs and their production
08/18/2011	WO2011077043A3 Phenol derivatives and pharmaceutical or cosmetic use thereof
08/18/2011	WO2011047323A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	US20110201634 Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same
08/18/2011	US20110201628 Heterocyclic jak kinase inhibitors
08/18/2011	US20110201609 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201592 Therapeutic Oxy-Phenyl-Aryl Compounds and Their Use
08/18/2011	US20110200619 Pharmaceutical compounds as cytotoxic agents and uses thereof
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP1797048B1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
08/17/2011	EP1773775B1 Six-membered heterocycles useful as serine protease inhibitors
08/17/2011	EP1761505B1 Pyrimidine urea derivatives as kinase inhibitors
08/17/2011	EP1670772B1 Derivatives of 1,3-diones having a herbicidal activity
08/17/2011	CN1913886B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/17/2011	CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses
08/17/2011	CN102159555A Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases
08/17/2011	CN102159547A Heterocyclic carboxamide compounds
08/17/2011	CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
08/17/2011	CN102153525A Preparation method and application of novel benzothiazole salt ionic liquid
08/17/2011	CN102153519A Preparation method of quinazoline derivative
08/17/2011	CN102153518A Preparation method of Gefitinib
08/17/2011	CN102153517A Diaryl pyrimidone hydrazone derivatives and preparation method and application of diaryl pyrimidone hydrazone derivatives
08/17/2011	CN102153516A Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
08/17/2011	CN102153481A Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
08/17/2011	CN102153463A 4-subsititued 3,5-dihydroxy carboxylic acid compound and preparation method thereof
08/17/2011	CN102153433A N-monosubstituted-alpha-carbonylamide compound and preparation method thereof
08/17/2011	CN102151270A Pyrimidine derivatives for the prevention of HIV infection
08/17/2011	CN101812024B Purification method of dimethyl murexide
08/16/2011	US7999109 CCR9 inhibitors and methods of use thereof
08/16/2011	CA2624749C Pyrimidine amide compounds as pgds inhibitors
08/11/2011	WO2011095053A1 Quinazoline derivatives, preparation methods and uses thereof
08/11/2011	WO2011073959A3 Crystal structure of the hiv-1 reverse transcriptase bound to a nucleotide-competitive reverse transcriptase inhibitor and the use thereof
08/11/2011	US20110196156 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
08/11/2011	US20110196149 Fluoridation method
08/11/2011	US20110196147 Inhibitors of histone deacetylase
08/11/2011	US20110195985 Compounds for the treatment of lysosomal storage diseases
08/11/2011	US20110195983 Quinazolinone derivatives useful as vanilloid antagonists
08/11/2011	US20110195979 Compounds for the treatment and prevention of influenza
08/11/2011	US20110195965 Tetrahydro- and dihydroquinazolinones
08/11/2011	US20110195939 Antitumor properties of no modified protease inhibitors
08/11/2011	US20110195018 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
08/11/2011	US20110193022 Five-ring liquid crystal compound having a nitrogen-containing heterocyclic ring, liquid crystal composition and liquid crystal display device

1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 427